Safety of vaginal delivery for preterm birth depends on fetal presentation
September 1st 2012Some studies indicate that planned cesarean delivery may reduce neonatal mortality compared with vaginal delivery for early preterm births. The safety of vaginal delivery in this scenario may depend on vertex versus breech presentation, however, according to a recent retrospective, multicenter cohort study.
Suspected Fetal Compromise: Is Deferred Delivery Best?
August 22nd 2012When fetal compromise is suspected, deferring delivery to allow the fetus more time in the womb until test results worsen or a favorable gestational age has been achieved may improve fetal and maternal outcomes, concluded a new study.
Poll: Should Researching the Relationship between the Environment and Maternal Health be a Priority?
August 21st 2012President-elect of ACOG, Jeanne Conry, MD,advocates for more awareness of and research into how environmental factors prior to conception influence the health of mother and baby, and said, “In medicine we often don't pay attention to environmental research." Is she right?
Lapatinib Plus Trastuzumab Improves Survival in Metastatic Breast Cancer
August 20th 2012In patients with heavily pretreated HER2-positive metastatic breast cancer, combination treatment with lapatinib and trastuzumab was associated with a median survival benefit of 4.5 months, according to the final results of a phase III study.
Managing Elevated Lead Levels in Pregnancy
August 17th 2012Because lead easily crosses the placenta, elevated lead levels in pregnancy have been associated with gestational hypertension, spontaneous abortion, low birth weight, and impaired neurodevelopment. In a new Committee Opinion, The American College of Obstetricians and Gynecologists has reviewed screening and management policies for elevated lead levels in pregnancy.
Timing of Endometrial Injury Matters in ART
August 15th 2012In women undergoing assisted reproductive techniques, intentional endometrial injury performed in the month prior to the embryo transfer cycle can increase the likelihood of clinical pregnancy and live birth, according to results of a new study.
A new option for preventing HIV in women?
August 2nd 2012Researchers are about to launch a large, multinational Phase III clinical trial to test the safety and effectiveness of a vaginal ring containing the experimental antiretroviral (ARV) drug dapivirine. The ring is intended to provide women with another means to prevent HIV acquisition through vaginal intercourse.